Restricted leptin antagonism as a therapeutic approach to treatment of autoimmune diseases

Hormones

Volumn 10, Issue 1, 2011, Pages 16-26

  Babaei, Arash ^a,b   Zarkesh Esfahani, Sayyed Hamid ^a   Bahrami, Ehsan ^a   Ross, Richard J ^c  

^a UNIVERSITY OF ISFAHAN   (Iran)

^b MALAYER UNIVERSITY   (Iran)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Adipocyte hormone; Antagonism; Autoimmune disease; Immune response; Leptin

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; LEPTIN; LEPTIN RECEPTOR; MONOCLONAL ANTIBODY CD3; RECOMBINANT LEPTIN; TUMOR NECROSIS FACTOR ALPHA; VERY LATE ACTIVATION ANTIGEN 2;

ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; CELLULAR IMMUNITY; COMMON VARIABLE IMMUNODEFICIENCY; DRUG BINDING SITE; DRUG RECEPTOR BINDING; ENDOMETRIOSIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOPHENOTYPING; IMMUNOREGULATION; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NONHUMAN; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL;

EID: 79951502581     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.1289     Document Type: Review

References (87)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM, 1994 Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432.
2. Zhang FM, Basinski MB, Beals JM, et al, 1997 Crystal structure of the obese protein leptin-E100. Nature 387: 206-209.
3. Baumann H, Morella KK, White DW, et al, 1996 The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci USA 93: 8374-8378.
4. Tartaglia LA, 1997 The leptin receptor. J Biol Chem 272: 6093-6096.
5. Halaas JL, Gajiwala KS, Maffei M, et al, 1995 Weightreducing effects of the plasma protein encoded by the obese gene. Science 269: 543-546.
6. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P, 1995 Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269: 546-549.
7. Pelleymounter MA, Cullen MJ, Baker MB, et al, 1995 Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543.
8. Laschober GT, Brunauer R, Jamnig A, Fehrer C, Greiderer B, Lepperdinger G, 2008 Leptin receptor/CD295 is upregulated on primary human mesenchymal stem cells of advancing biological age and distinctly marks the subpopulation of dying cells. Exp Gerontol 44: 57-62.
9. Chen H, Charlat O, Tartaglia LA, et al, 1996 Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell 84: 491-495.
10. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Trayhurn P, 1996 Localization of leptin receptor mRNA and the long form splice variant (Ob- Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett 387: 113-116.
11. Hegyi K, Fulop K, Kovacs K, Toth S, Falus A, 2004 Leptin-induced signal transduction pathways. Cell Biol Int 28: 159-169.
12. Sinha MK, Opentanova I, Ohannesian JP, et al, 1996 Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest 98: 1277-1282.
13. Saladin R, Devos P, Guerremillo M, et al, 1995 Transient increase in obese gene-expression after food-intake or insulin administration. Nature 377: 527-529.
14. Lee GH, Proenca R, Montez JM, et al, 1996 Abnormal splicing of the leptin receptor in diabetic mice. Nature 379: 632-635.
15. Friedman JM, Halaas JL, 1998 Leptin and the regulation of body weight in mammals. Nature 395: 763-770.
16. Park JH, Lee HH, Na SY, et al, 2001 Recombinant expression of biologically active rat leptin in Escherichia coli. Protein Expr Purif 22: 60-69.
17. Sierra-Honigmann MR, Nath AK, Murakami C, et al, 1998 Biological action of leptin as an angiogenic factor. Science 281: 1683-1686.
18. Ducy P, Amling M, Takeda S, et al, 2000 Leptin Inhibits Bone Formation through a Hypothalamic Relay A Central Control of Bone Mass. Cell 100: 197-207.
19. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI, 1998 Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394: 897-901.
20. Sanchez-Margalet V, Martin-Romero C, Santos-Alvarez J, Goberna R, Najib S, Gonzalez-Yanes C, 2003 Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action. Clin Exp Immunol 133: 11-19.
21. Tartaglia LA, Dembski M, Weng X, et al, 1995 Identification and expression cloning of a leptin receptor, OB-R. Cell 83: 1263-1271.
22. Matarese G, La Cava A, Sanna V, et al, 2002 Balancing susceptibility to infection and autoimmunity: a role for leptin? Trends Immunol 23: 182-187.
23. Ducy P, Amling M, Takeda S, et al, 2000 Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 100: 197-207.
24. Peelman F, Iserentant H, Eyckerman S, Zabeau L, Tavernier J, 2005 Leptin, immune responses and autoimmune disease. Perspectives on the use of leptin antagonists. Curr Pharm Des 11: 539-548.
25. Chehab FF, Lim ME, Lu RH, 1996 Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 12: 318-320.
26. Howard JK, Lord GM, Matarese G, et al, 1999 Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest 104: 1051-1059.
27. Frank S, Stallmeyer B, Kampfer H, Kolb N, Pfeilschifter J, 2000 Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair. J Clin Invest 106: 501-509.
28. Ring BD, Scully S, Davis CR, et al, 2000 Systemically and topically administered leptin both accelerate wound healing in diabetic ob/ob mice. Endocrinology 141: 446-449.
29. Fleet JC, 2000 Leptin and bone: Does the brain control bone biology? Nutr Rev 58: 209-211.
30. Faggioni R, Moser A, Feingold KR, Grunfeld C, 2000 Reduced leptin levels in starvation increase susceptibility to endotoxic shock. Am J Pathol 156: 1781-1787.
31. Faggioni R, Jones-Carson J, Reed DA, et al, 2000 Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: Role of tumor necrosis factor alpha and IL-18. Proc Natl Acad Sci USA 97: 2367-2372.
32. Mandel MA, Mahmoud AAF, 1978 Impairment of cellmediated immunity in mutation diabetic mice (db/db). J Immunol 120: 1375-1377.
33. Chandra RK, 1980 Cell-mediated immunity in genetically obese C57BL/6J ob/ob) mice. Am J Clin Nutr 33: 13-16.
34. Lord GM, Matarese G, Howard LK, Baker RJ, Bloom SR, Lechler RI, 1998 Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394: 897-901.
35. Martin-Romero C, Santos-Alvarez J, Goberna R, Sanchez-Margalet V, 2000 Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol 199: 15-24.
36. Ozata M, Ozdemir IC, Licinio J, 2000 Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects (vol 84, pg 3686, 1999). J Clinl Endocrinol Metab 85: 416-416.
37. Samartin S, Chandra RK, 2001 Obesity, overnutrition and the immune system. Nutrition Research 21: 243-262.
38. Lord GM, Matarese G, Howard JK, Bloom SR, Lechler RI, 2002 Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leukoc Biol 72: 330-338.
39. La Cava A, Matarese G, 2004 The weight of leptin in immunity. Nat Rev Immunol 4: 371-379.
40. Tian ZG, Sun R, Wei HM, Gao B, 2002 Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation. Biochem Biophys Res Commun 298: 297-302.
41. Landman RE, Puder JJ, Xiao E, Freda PU, Ferin M, Wardlaw SL, 2003 Endotoxin stimulates leptin in the human and nonhuman primate. J Clin Endocrinol Metab 88: 1285-1291.
42. Orbak Z, Ertekin V, Akcay F, Ozkan B, Ors R, 2003 Serum leptin levels in neonatal bacterial septicemia. J Pediatr Endocrinol Metab16: 727-731.
43. Loffreda S, Yang SQ, Lin HZ, et al, 1998 Leptin regulates proinflammatory immune responses. Faseb Journal 12: 57-65.
44. Gainsford T, Willson TA, Metcalf D, et al, 1996 Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl Acad Sci USA 93: 14564-14568.
45. Zarkesh-Esfahani H, Pockley G, Metcalfe RA, et al, 2001 High-dose leptin activates human leukocytes via receptor expression on monocytes. J Immunol 167: 4593-4599.
46. Zarkesh-Esfahani H, Pockley AG, Wu ZD, Hellewell PG, Weetman AP, Ross RJM, 2004 Leptin indirectly activates human neutrophils via induction of TNF-alpha. J Immunol 172: 1809-1814.
47. Meier CA, Chicheportiche R, Dreyer M, Dayer JM, 2003 IP-10, but not RANTES, is upregulated by leptin in monocytic cells. Cytokine 21: 43-47.
48. Taub DD, Lloyd AR, Conlon K, et al, 1993 Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 177: 1809.
49. Mach F, Sauty A, Iarossi AS, et al, 1999 Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J Clin Invest 104: 1041-1050.
50. Heymsfield SB, Greenberg AS, Fujioka K, et al, 1999 Recombinant leptin for weight loss in obese and lean adults - A randomized, controlled, dose-escalation trial. JAMA 282: 1568-1575.
51. Ozata M, Ozdemir IC, Licinio J, 1999 Human leptin deficiency caused by a missense mutation: Multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 84: 3686-3695.
52. Ozata M, Uckaya G, Beyhan Z, Ozdemir IC, 1999 Plasma leptin levels in male patients with idiopathic central diabetes insipidus. Journal of Endocrinological Investigation 22: 451-454.
53. Siegmund B, Lehr HA, Fantuzzi G, 2002 Leptin: A pivotal mediator of intestinal inflammation in mice. Gastroenterology 122: 2011-2025.
54. Mykoniatis A, Anton PM, Wlk M, et al, 2003 Leptin mediates Clostridium difficile toxin A-induced enteritis in mice. Gastroenterology 124: 683-691.
55. Matarese G, Sanna V, Di Giacomo A,et al, 2001 Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males. Eur J Immunol 31: 1324-1332.
56. Garcia-Gonzalez A, Gonzalez-Lopez L, Valera-Gonzales IC, et al, 2002 Serum leptin levels in women with systemic lupus erythematosus. Rheumatol Int 22: 138-141.
57. Ren H, Zhao H, Wang TT, et al, 2006 Leptin enhances in vitro secretion of IgG antiplatelet antibodies by splenocytes and peripheral blood mononuclear cells from patients with chronic idiopathic thrombocytopenic purpura. Clin Immunol 120: 205-211.
58. Busso N, So A, Chobaz-Peclat V, et al, 2002 Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 168: 875-882.
59. Matarese G, Sanna V, Lechler RI, et al, 2002 Leptin accelerates autoimmune diabetes in female NOD mice. Diabetes 51: 1356-1361.
60. Cooper GS, Stroehla BC, 2003 The epidemiology of autoimmune diseases. Autoimm Rev 2: 119-125.
61. Matarese G, Sanna V, Fontana S, Zappacosta S, 2002 Leptin as a Novel Therapeutic Target for Immune Intervention. Curr Drug Targets Inflamm Allergy 1: 13-22.
62. Matarese G, Moschos S, Mantzoros CS, 2005 Leptin in immunology. J Immunol 174: 3137-3142.
63. Gertler A, 2006 Development of leptin antagonists and their potential use in experimental biology and medicine. Trends Endocrinol Metab 17: 372-378.
64. Verploegen S, Plaetinck G, Devos R, van der Heyden J, Guisez Y, 1997 A human leptin mutant induces weight gain in normal mice. FEBS Lett 405: 237-240.
65. Peelman F, Van Beneden K, Zabeau L, et al, 2004 Mapping of the leptin binding sites and design of a leptin antagonist. J Biol Chem 279: 41038-41046.
66. de Barsy T, Directeur W. Geneeskundige Stichting Koningin Elisabeth 2006 Inleiding Verslag Activiteiten van de GSKE-FMRE.
67. Steidler L, Hans W, Schotte L, et al, 2000 Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289: 1352.
68. Steidler L, Neirynck S, Huyghebaert N, et al, 2003 Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat Biotechnol 21: 785-789.
69. Lam QLK, Lu L, 2007 Role of leptin in immunity. Cell Mol Immunol 4: 1-13.
70. Wu ZD, Bidlingmaier M, Liu CL, et al, 2002 Quantification of the soluble leptin receptor in human blood by ligand-mediated immunofunctional assay. J Clin Endocrinol Metab 87: 2931-2939.
71. Laimer M, Ebenbichler CF, Kaser S, et al, 2002 Weight loss increases soluble leptin receptor levels and the soluble receptor bound fraction of leptin. Obes Res 10: 597-601.
72. Huang L, Wang ZW, Li C, 2001 Modulation of circulating leptin levels by its soluble receptor. J Biol Chem 276: 6343-6349.
73. van Dielen FM, van't Veer C, Buurman WA, Greve JWM, 2002 Leptin and soluble leptin receptor levels in obese and weight-losing individuals. J Clin Endocrinol Metab 87: 1708-1716.
74. Fazeli M, Zarkesh-Esfahani H, Wu ZD, et al, 2006 Identification of a monoclonal antibody against the leptin receptor that acts as an antagonist and blocks human monocyte and T cell activation. J Immunol Methods 312: 190-200.
75. Wannamethee SG, Tchernova J, Whincup P, et al, 2007 Plasma leptin: Associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis 191: 418-426.
76. Elinav E, Abd-Elnabi A, Pappo O, et al, 2006 Suppression of hepatocellular carcinoma growth in mice via leptin, is associated with inhibition of tumor cell growth and natural killer cell activation. J Hepatol 44: 529-536.
77. De Rosa V, Procaccini C, Cali G, et al, 2007 A key role of leptin in the control of regulatory T cell proliferation. Immunity 26: 241-255.
78. Goldberg AC, Eliaschewitz FG, Montor WR, et al, 2005 Exogenous leptin restores in vitro T cell proliferation and cytokine synthesis in patients with Common Variable Immunodeficiency Syndrome. Clin Immunol 114: 147-153.
79. Stofkova A, Skurlova M, Tybitanclova K, Veselsky L, Zelezna B, Jurcovicova J, 2006 Relationship among nitric oxide, leptin, ACTH, corticosterone, and IL-1 beta, in the early and late phases of adjuvant arthritis in male Long Evans rats. Life Sci 79: 2486-2491.
80. Singh P, Hoffmann M, Wolk R, Shamsuzzaman ASM, Somers VK, 2007 Leptin induces C-reactive protein expression in vascular endothelial cells. Arterioscler Thromb Vasc Biol 27: E302-E307.
81. Lafrance V, Inoue W, Kan B, Luheshi GN, 2009 Leptin modulates cell morphology and cytokine release in microglia. Brain, Behavior, and Immunity. Brain Behav Immun 24: 358-365.
82. Park MC, Chung SJ, Park YB, Lee SK, 2009 Pro-inflammatory effect of leptin on peripheral blood mononuclear cells of patients with ankylosing spondylitis. Joint Bone Spine 76: 170-175.
83. Angelucci F, Mirabella M, Caggiula M, et al, 2005 Evidence of involvement of leptin and IL-6 peptides in the action of interferon-beta in secondary progressive multiple sclerosis. Peptides 26: 2289-2293.
84. Milewski L, Barcz E, Dziunycz P, et al, 2008 Association of leptin with inflammatory cytokines and lymphocyte subpopulations in peritoneal fluid of patients with endometriosis. J Reprod Immunol 79: 111-117.
85. Frisullo G, Mirabella M, Angelucci F, et al, 2007 The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. J Neuroimmunol 192: 174-183.
86. Sanna V, Di Giacomo A, La Cava A, et al, 2003 Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J Clin Invest 111: 241-250.
87. Matarese G, Carrieri PB, La Cava A, et al, 2005 Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25(+) regulatory T cells. Proc Natl Acad Sci USA 102: 5150-5155.